Medica 2026
Nov 16-19, 2026 - Düsseldorf, Germany

What's the Difference Between Influenza A and B?

What Is Influenza Virus?

Influenza viruses are enveloped negative-sense RNA viruses. The segmented nature of the genome consists of 8 segments. These segments encode proteins for a variety of functions, including hemagglutinin and neuraminidase, which are two surface glycoproteins. HA allows the virus to enter the host cell, and NA helps newly formed viruses leave the infected cell.

There are two primary ways influenza viruses escape recognition from the immune system: antigenic drift and antigenic shift.

We provide influenza virus-related antigens, antibodies, and other reagents to support research and vaccine innovation.

Influenza Virus Antibodies Influenza Virus Antigens Influenza A Virus Antigens Influenza B Virus Antigens Recombinant Antigens for Influenza Vaccine Strains

Browse All Our Influenza Virus-Related Products

Classification of Influenza Viruses

Influenza viruses are divided into 4 types based on antigenic characteristics, with different epidemiological and pathogenic properties: A, B, C, and D.

IAV

  • The most frequent cause of seasonal influenza, can cause mild to severe disease in humans and infects many different animal species.
  • There are 16 known HA subtypes and 9 known NA subtypes. The subtypes can be combined into many different subtypes (H1N1, H5N1, H7N9, etc.).

IBV

  • Mainly infects humans, occasionally causing localized small outbreaks. It undergoes antigenic drift but has no subtype classification and is less prevalent than IAV.

ICV

  • Primarily infects humans and can cause mild respiratory symptoms in animals like pigs, usually resulting in sporadic cases.

IDV

  • Mainly circulates in pigs and cattle, with no evidence of human infection to date.

Table 1. Different types of influenza virus. (Source: Javanian M, et al. 2021)

Type of influenzaSymptomsAffectSubgroupsEpidemiology
AMild to severeAnimal and humanDivided based on the antigenic properties (16 hemagglutinin and 9 neuraminidase)Widespread
BMildOnly humanNot classified by subtypeNot cause pandemics
CMildHuman and some animalsNot classified by subtypeNot cause epidemics
DMildAnimals, unknown in humanNot classified by subtypeNot Widespread

Virological Differences Between IAV and IBV

IAV structureFigure 1. The structure of influenza A virus. (Source: Jung HE, et al. 2020)

IAV's genome consists of eight segments of negative-sense RNA encoding 11 proteins. HA, NA, and M2 are transmembrane proteins embedded in the lipid envelope. Each RNA segment forms a vRNP composed of viral RNA and NP, which associates with the RNA polymerase complex. The M1 protein is located inside the viral envelope and interacts with vRNPs. HA is responsible for receptor binding and membrane fusion. NA is involved in viral release, and the M2 ion channel helps regulate endosomal pH to allow for vRNP release. IAVs cause seasonal outbreaks and pandemics, due to the high frequency of genetic mutation and reassortment between subtypes.

Both IAV and IBV are segmented negative-sense RNA viruses with eight genome segments, but IBV has higher genomic stability than IAV. The antigenic diversity of IBV's HA and NA is lower than that of IAV, with IBV divided into only two lineages: Victoria and Yamagata. IBV lacks accessory proteins like PB1-F2. The proteins of IAV and IBV differ significantly in length, amino acid composition, and function. Currently, IBV is classified into two genetically and antigenically distinct lineages, B/Victoria/2/1987-like and B/Yamagata/16/1988-like. IBV exhibits a slower rate of antigenic drift. These differences make IAV more likely to cause pandemics, while IBV mainly causes seasonal epidemics.

IBV structureFigure 2. Schematic of IBV. (Source: Koutsakos M, et al. 2016)

Comparison of IAV and IBV

Table 2. Differences between influenza A and influenza B viruses.
(Source: Ashraf MA, et al. 2024)

CharacteristicsIAVIBV
PhylogeneticsSubtyped by NA and HA (e.g., H3N2 and H1N1)According to HA, have two lineages: Yamagata and Victoria
Host rangeLikely animal hosts and many animal reservoirsAnimal reservoirs not established
Age susceptibilityMost severe in elderly and childrenMost severe in adolescence and children
EpidemiologyPandemic potential, global impactTypically causes localized outbreaks, less global impact
Typically causes localized outbreaks, less global impactRange from mild to severe respiratory symptom
Can lead to complications such as pneumonia and bronchitis
Avian strains caused severe diseases and high death rates
Similar symptoms to influenza A but milder
Less likely to cause severe complications
Caused severe health problems in children
ImmunologyM1 and NP are the major CD8+ T-cell antigens
Generally, strong IFN-αβ and cytokine response
HA is the major antibody target
Major CD8+ T-cell antigens are unknown strong IFN-αβ and cytokine response, details unclear
HA is the major antibody target
AntiviralsAdamantanes used are effective
NAIs effective, but resistance detected
Adamantanes are ineffective
NAIs effective, but resistance detected, in some cases without apparent fitness cost

More Influenza Viruses Related Resources

References

  1. Javanian M, et al. A brief review of influenza virus infection. J Med Virol. 2021 Aug;93(8):4638-4646.
  2. Havasi A, et al. Influenza A, Influenza B, and SARS-CoV-2 Similarities and Differences - A Focus on Diagnosis. Front Microbiol. 2022 Jun 20;13:908525.
  3. Jung HE, et al. Host Protective Immune Responses against Influenza A Virus Infection. Viruses. 2020 May 3;12(5):504.
  4. Koutsakos M, et al. Knowns and unknowns of influenza B viruses. Future Microbiol. 2016;11(1):119-35.
  5. Ashraf MA, et al. A comprehensive review of influenza B virus, its biological and clinical aspects. Front Microbiol. 2024 Sep 4;15:1467029.
Inquiry Basket
loading Loading ......

Inquiry

Inquiry